Patent · US Active

Process for screening glycoform-specific antibodies

US8431355B2 · kind B2 · utility

1Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 4, 2005
Grant dateApr 30, 2013
Priority date
Expiry dateJan 26, 2028

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/6854
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to the use of the assessment of the binding between—antibodies elicited against a first glycoprotein, and—at least one glycoform of a second glycoprotein, said second glycoprotein being itself a glycoform of the first protein, wherein said glycoform of the second glycoprotein is selected from a group of glycoforms of the second glycoprotein, each glycoform of said group corresponding to a determined glycosylation state defined by a determined sialylation state, and/or a determined branching state, and/or a determined fucosylation state, provided that said glycosylation state is not uniquely defined by a substantially unsialylated state, for the screening of glycoform specific antibodies directed against a given glycoform of the second glycoprotein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.